Artwork

Content provided by Heart Management. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Heart Management or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

088. Klaus Moosmayer: Cultivating Trust and Ethical Leadership at a Global Pharmaceutical Company

43:32
 
Share
 

Manage episode 411835904 series 2993271
Content provided by Heart Management. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Heart Management or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Klaus Moosmayer joined Novartis in 2018 as Chief Ethics, Risk and Compliance Officer and a member of the Executive Committee. He was previously chief compliance officer at Siemens AG, where he spent 18 years in roles of increasing seniority. He began his career as a lawyer in Germany, specializing in white-collar crime, business law and litigation.

In this episode we explore the reality of ethical dilemmas in the corporate world, the importance of building trust, especially in the pharmaceutical industry, and the value of creating an inviting atmosphere for discussions on ethics and compliance. Klaus also discusses the development of a new code of ethics at Novartis – likening it to the company's constitution.

Links Mentioned:

Cultureandleadership.org

‘Blind Spots’ by Ann Tenbrunsel and Max Bazerman

Klaus Moosmayer on LinkedIn

  continue reading

98 episodes

Artwork
iconShare
 
Manage episode 411835904 series 2993271
Content provided by Heart Management. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Heart Management or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Klaus Moosmayer joined Novartis in 2018 as Chief Ethics, Risk and Compliance Officer and a member of the Executive Committee. He was previously chief compliance officer at Siemens AG, where he spent 18 years in roles of increasing seniority. He began his career as a lawyer in Germany, specializing in white-collar crime, business law and litigation.

In this episode we explore the reality of ethical dilemmas in the corporate world, the importance of building trust, especially in the pharmaceutical industry, and the value of creating an inviting atmosphere for discussions on ethics and compliance. Klaus also discusses the development of a new code of ethics at Novartis – likening it to the company's constitution.

Links Mentioned:

Cultureandleadership.org

‘Blind Spots’ by Ann Tenbrunsel and Max Bazerman

Klaus Moosmayer on LinkedIn

  continue reading

98 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide